Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trial

CONCLUSIONS: Oral MP is cost-effective in the treatment of multiple sclerosis relapses and associated with major savings.PMID:34598781 | DOI:10.1016/j.neurol.2021.06.009
Source: Revue Neurologique - Category: Neurology Authors: Source Type: research